Guidelines on the Use of Therapeutic Apheresis in Clinical PracticeEvidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

Guidelines on the Use of Therapeutic Apheresis in Clinical PracticeEvidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
复制标题

DOI:
10.1002/jca.21276
复制
发表时间:
2013-07-01
影响因子:
1.5
通讯作者:
Shaz, Beth H.
Shaz, Beth H.
中科院分区:
医学4区
文献类型:
--
作者:
Schwartz, Joseph;Winters, Jeffrey L.;Shaz, Beth H.

文献摘要

被引文献

相似文献

美国Apheresis协会(ASFA)JCA特刊撰写委员会负责审查、更新和分类治疗性分离的适应症。从2007年ASFA特刊(第四版)开始,委员会在适应症的分级和分类中纳入了系统审查和循证方法。ASFA特刊的第六版通过始终如一地应用类别和等级系统定义,但由于等级和大学医疗联盟系统之间的冗余,消除了先前版本中使用的证据标准(来自大学医疗保健联盟),进一步改进了建议中使用循证医学的过程。第四版和第五版中使用的概况介绍的总体布局和概念在这一版本中基本保持不变。每一份情况说明书都简明扼要地总结了在特定疾病实体中使用治疗性分离的证据。本文包括78份情况说明书(自2010年起增加),涉及ASFA第一类至第四类的治疗适应症,其中许多疾病被分类,具有多种临床表现/情况,并分别进行分级和分类。J·克莱恩。分离28:145-284,2013。(C)2013年威利期刊公司。
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is charged with reviewing, updating and categorizating indications for therapeutic apheresis. Beginning with the 2007 ASFA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approach in the grading and categorization of indications. This Sixth Edition of the ASFA Special Issue has further improved the process of using evidence-based medicine in the recommendations by consistently applying the category and GRADE system definitions, but eliminating the level of evidence criteria (from the University HealthCare Consortium) utilized in prior editions given redundancy between GRADE and University HealthCare Consortium systems. The general layout and concept of a fact sheet that was utilized in the Fourth and Fifth Editions, has been largely maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of therapeutic apheresis in a specific disease entity. This article consists of 78 fact sheets (increased from 2010) for therapeutic indications in ASFA categories I through IV, with many diseases categorized having multiple clinical presentations/situations which are individually graded and categorized. J. Clin. Apheresis 28:145-284, 2013. (c) 2013 Wiley Periodicals, Inc.